Preventing Adverse Drug Events With PatientSite

NACompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Adverse Drug Event
Interventions
OTHER

Medcheck message

Participants selected at random will receive one email message asking them questions about their prescription which will be forwarded to their physician

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

collaborator

Blue Cross Blue Shield

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00140504 - Preventing Adverse Drug Events With PatientSite | Biotech Hunter | Biotech Hunter